Physician profile
David Elison
NPI 1306230990
$17,051.67
in general payments reported to CMS, 2019-2025
13 companies · $8,335 in 2025
The $8,335 reported for 2025 was more than what 88% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $124 · 2022: $3,194 · 2023: $1,447 · 2024: $3,951 · 2025: $8,335.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $7,063 · Food and Beverage: $6,141 · Consulting Fee: $530.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $7,062.84 |
| Food and Beverage | $6,140.63 |
| Consulting Fee | $530.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $9,299.44 | 2022-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv), Pascal |
| Abbott Laboratories | $4,916.64 | 2022-2025 | Mitraclip, Triclip, Navitor |
| Medtronic, INC. | $710.83 | 2023-2025 | Corevalve Evolut R, Avalus, Apollotm |
| Philips North America LLC | $563.43 | 2025 | Igt Devices Undivided |
| Boston Scientific Corporation | $384.03 | 2022-2025 | Watchman Flx, Stingray, General - Atherectomy |
| Heartflow, INC. | $229.18 | 2024 | |
| Shockwave Medical, INC | $218.34 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abiomed | $187.68 | 2024-2025 | Impella |
| Biotronik INC. | $170.68 | 2022 | |
| Cardiovascular Systems INC. | $124.34 | 2021 | |
| W. L. Gore & Associates, INC. | $123.42 | 2025 | Gore Cardioform Septal Occluder |
| Cardiva Medical, INC. | $105.19 | 2024-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade Mvp Xl Vvcs 10-12f, Cardiva Vascade 6/7f Vcs |
| Terumo Medical Corporation | $18.47 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Elison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.